A Curated Platform of Equity & Options Market Intelligence
Select Page

ZYME

Search by
TICKER SYMBOL

Zymeworks BC Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

6.46

-0.18

(-2.711%)

Volume:

0

52 week range:

4.86 - 10.8

Market Cap:

438.16M

Company Description:

zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company’s novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics targeted across a range of indications. zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. more information on zymeworks can be found at www.zymeworks.com.